Duodenal switch: Long-term results

Obesity Surgery

Volumn 17, Issue 11, 2007, Pages 1421-1430

  Marceau, Picard ^a   Biron, Simon ^a   Hould, Frédéric Simon ^a   Lebel, Stéfane ^a   Marceau, Simon ^a   Lescelleur, Odette ^a   Biertho, Laurent ^a   Simard, Serge ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bariatric surgery; Duodenal switch; Long term results; Morbid obesity

Indexed keywords

ALPHA TOCOPHEROL; ANTIASTHMATIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; RETINOL; VITAMIN D; VITAMIN K GROUP;

ANEMIA; ARTICLE; ASTHMA; BILIOPANCREATIC BYPASS; BLOATING; BONE INJURY; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INCISIONAL HERNIA; INTERMETHOD COMPARISON; INTESTINE OBSTRUCTION; LIVER INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORBID OBESITY; NEPHROLITHIASIS; NUTRITIONAL ASSESSMENT; OBESITY; PATIENT SATISFACTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH BYPASS; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; VITAMIN DEFICIENCY; WEIGHT REDUCTION; ADOLESCENT; ADULT; AGED; BARIATRIC SURGERY; BODY MASS; METHODOLOGY; MIDDLE AGED; MORTALITY; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; BODY MASS INDEX; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OBESITY, MORBID; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 39749163051     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9435-9     Document Type: Article

References (23)

1. Marceau P, Hould FS, Lebel S et al. Malabsorptive obesity surgery. Surg Clin North Am 2001; 81: 1113-27.
2. Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-54.
3. Holst JJ. Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterol 1994; 107: 1848-55.
4. Ballinger A. Gastric inhibitory polypeptide links overnutrition to obesity. Science@lert. www.gutjnl.com
5. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg 2004; 239: 1-11.
6. Marceau P. Contribution of bariatric surgery to the comprehension of morbid obesity. Obes Surg 2005; 15: 3-10.
7. Marceau S, Biron S, Lagacé M et al. Biliopancreatic diversion, with distal gastrectomy, 250 cm and 50 cm limbs: long-term results. Obes Surg 1995; 5: 302-7.
8. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 2004; 199: 543-51.
9. Institut de la Statistique Quebec 25 avril 2006. http://www.stat.gouv.qc. ca/donstat/societe/demographic/maison deces/307.htm
10. Katzmarzyk PT, Craig CL, Bouchard C. Underweight, overweight and obesity: relationships with mortality in the 13-year follow-up of the Canada Fitness Survey. J Clin Epidemiol 2001; 54: 916-20.
11. Sjostrom L, Narbro K, Sjostrom CD et al. Effects of bariatric surgery on mortality in Sweddish obese subjects. N Engl J Med 2007; 357: 741-52.
12. Ten-year follow-up of weight loss and quality of life after obesity treatment. Swedish obese subjects (SOS) - An intervention study of obesity. Quality of Life Res 2003; 12: 805.
13. DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Rel Dis 2007; 3: 134-40.
14. Hamoui N, Chock B, Anthone GJ et al. Revision of the duodenal switch: indications, technique, and outcomes. J Am Coll Surg 2007; 204: 603-730.
15. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-73.
16. Parfitt AM, Podenphant J, Villanueva AR et al. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery. Bone 1985; 6: 211-20.
17. Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002; 6: 690-8.
18. Blanchet C, Dodin S, Dumont M et al. Bone mineral density in French Canadian women. Osteoporosis Int 1998; 8: 268-73.
19. Palomar R, Fernandez-Fresnedo G, Dominguez-Diez A et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg 2005; 15: 794-8.
20. Wayne KN, Houghton SG, Dawn SM et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy potentially serious and unappreciated complications of Roux gastric bypass. Surg Obes Rel Dis 2005; 1: 481-5.
21. Nelson WK, Fatima J, Houghton SG et al. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery 2006; 140: 517-23.
22. Brolin RE. Prospective, randomized evaluation of midline fascial closure in gastric bariatric operations. Am J Surg 1996; 172: 328-31.
23. Sugerman HJ, Kellum JM, Reines HD et al. Greater risk of incisional hernia with morbidly obese than steroiddependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 1996; 171: 80-4.